• This is a Healthcare Effectiveness & Data Information Set (HEDIS®) administrative measure and only includes Medicaid Primary beneficiaries.
• The annual reported rate captures activity during the stated measurement year (MY).

The Healthcare Effectiveness Data and Information Set (HEDIS®) is a registered trademark of NCQA.

The percentage of women ages 21 to 64 who were screened for cervical cancer using either of the following criteria:

• Women ages 21 to 64 who had cervical cytology performed every 3 years
• Women ages 30 to 64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years

Cervical cancer can be detected in its early stages by regular screening using a Pap (cervical cytology) test.  A number of organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Medical Association (AMA) and the American Cancer Society (ACS) recommend Pap testing every one to three years for all women who have been sexually active or who are over 21.

Last updated:  August 2021